From our evidence base to continuing medical education, Dr. David Healy reveals the vast influence of pharmaceutical marketing and offers tips on how to minimize bias.

Are stimulant medication likely to exacerbate anxiety in ADHD kids? It’s reasonable concern, especially since mood symptoms can be worse with withdrawal and heart rate goes up in some kids on stimulants. This study gives nuanced insight into the degree to which stimulants impact anxiety in ADHD kids, for better and worse.

Parents suffer significant stress, doing their best to support and care for their ADHD kids. Does that stress dissipate at all when the ADHD is alleviated? This controlled trial looked at stress levels of parents whose kids were taking delayed release/extended release methylphenidate versus those taking placebo. 

With so many medications and supplements to try for ADHD, what combinations are effective? This research update looks at a study that tested whether adding Co-Q10 to atomoxetine treatment might improve outcomes in ADHD. Our analysis of this approach is a guide to other combination approaches to ADHD.

Neurofeedback enjoys active marketing for multiple conditions, including treatment of ADHD, but what is the current state of the research supporting this pricey approach? This research update reports on a recent study and puts the use of neurofeedback in context so you can better guide families on whether to try it.

Richard Brown advances our understanding of CAM treatments for ADHD and updates us on what works and what doesn’t in clinical practice.